Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
PMID: 41887313 Nanoscale Targeting glutamine metabolism combined with a nanoradioenhancer in radioresistant hepatocellular carcinoma
The company has a broad range of pharma drugs with DCGI approval
Wang DH, Li DC, Zhang GC, Wang CL, Wei GY (2019) Disruption of por1 gene in Candida utilis improves co-production of S-adenosylmethionine and glutathione
Furthermore, recent studies point to possible protection against macular degeneration and heart disease by lowering homocysteine levels
:max_bytes(150000):strip_icc()/VWH-GettyImages-2275860768-a6f6e63304e048d0a829844c1dacbd8d.jpg)
US$ 28.02
US$ 29.28
